Cargando…
Decrease in drug accumulation and in tumour aggressiveness marker expression in a fenretinide-induced resistant ovarianumour cell line
We investigated whether the efficacy of fenretinide (HPR) against ovarian tumours may be limited by induction of resistance. The human ovarian carcinoma cell line A2780, which is sensitive to a pharmacologically achievable HPR concentration (IC (50)= 1 μM), became 10-fold more resistant after exposu...
Autores principales: | Appierto, V, Cavadini, E, Pergolizzi, R, Cleris, L, Lotan, R, Canevari, S, Formelli, F |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2001
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363672/ https://www.ncbi.nlm.nih.gov/pubmed/11384104 http://dx.doi.org/10.1054/bjoc.2001.1826 |
Ejemplares similares
-
4-oxo-N-(4-hydroxyphenyl)retinamide: Two Independent Ways to Kill Cancer Cells
por: Tiberio, Paola, et al.
Publicado: (2010) -
Sodium 4-Carboxymethoxyimino-(4-HPR) a Novel Water-Soluble Derivative of 4-Oxo-4-HPR Endowed with In Vivo Anticancer Activity on Solid Tumors
por: Tiberio, Paola, et al.
Publicado: (2017) -
Verapamil potentiation of doxorubicin resistance development in B16 melanoma cells both in vitro and in vivo.
por: Formelli, F., et al.
Publicado: (1988) -
Stromal accumulation of chondroitin sulphate in mammary tumours of dogs
por: Hinrichs, U, et al.
Publicado: (1999) -
Pharmacokinetics and effects on plasma retinol concentrations of 13-cis-retinoic acid in melanoma patients.
por: Formelli, F., et al.
Publicado: (1997)